Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.

Administration of ivermectin (IVM) as part of mass drug administration (MDA) campaigns for onchocerciasis and/or lymphatic filariasis (LF) has been suspended in areas co-endemic for Loa loa due to severe post-treatment adverse events (SAEs) associated with high-burden of infection (>30,000 mf/ml)...

Full description

Bibliographic Details
Main Authors: Sasisekhar Bennuru, Sébastien D S Pion, Joseph Kamgno, Samuel Wanji, Thomas B Nutman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-09-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4169247?pdf=render
id doaj-ae39040a82d0497486a9197819c0799e
record_format Article
spelling doaj-ae39040a82d0497486a9197819c0799e2020-11-25T02:34:04ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-09-0189e318010.1371/journal.pntd.0003180Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.Sasisekhar BennuruSébastien D S PionJoseph KamgnoSamuel WanjiThomas B NutmanAdministration of ivermectin (IVM) as part of mass drug administration (MDA) campaigns for onchocerciasis and/or lymphatic filariasis (LF) has been suspended in areas co-endemic for Loa loa due to severe post-treatment adverse events (SAEs) associated with high-burden of infection (>30,000 mf/ml). One simple approach for preventing SAEs is to identify and exclude individuals at risk from MDA. Here, we describe a repurposed hand-held automated cell counter (Scepter 2.0; HHAC) as a rapid, point-of-care method for quantifying microfilariae (mf) in the blood of infected individuals.The quantification of microfilarial levels in blood of naturally infected humans, experimentally infected baboons, or mf-spiked human blood was tested using a microfluidic-based automated counter and compared to traditional calibrated thick-smears. We demonstrate that mf can be quantified in 20 µl of whole blood following lysis with 10% saponin within a minute of obtaining blood. There was a highly significant concordance between the counts obtained by the HHAC and those by microscopy for mf densities of >5,000 (p<0.0001, r(c) = 0.97) or >30,000 per ml (p<0.0001, r(c) = 0.90). Preliminary proof of concept field studies in Cameroon with 20 µl of blood from L. loa infected humans (n = 22) and baboons (n = 4) also demonstrated a significantly high concordance (p<0.0001, r(c) = 0.89) with calibrated thick blood smears counts.A repurposed HHAC is a portable, sensitive, rapid, point-of-care and quantitative tool to identify individuals with high levels of L. loa mf that put them at risk for SAEs following MDA. In addition, it provides ease of data storage and accessibility.http://europepmc.org/articles/PMC4169247?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Sasisekhar Bennuru
Sébastien D S Pion
Joseph Kamgno
Samuel Wanji
Thomas B Nutman
spellingShingle Sasisekhar Bennuru
Sébastien D S Pion
Joseph Kamgno
Samuel Wanji
Thomas B Nutman
Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
PLoS Neglected Tropical Diseases
author_facet Sasisekhar Bennuru
Sébastien D S Pion
Joseph Kamgno
Samuel Wanji
Thomas B Nutman
author_sort Sasisekhar Bennuru
title Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
title_short Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
title_full Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
title_fullStr Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
title_full_unstemmed Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
title_sort repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2727
1935-2735
publishDate 2014-09-01
description Administration of ivermectin (IVM) as part of mass drug administration (MDA) campaigns for onchocerciasis and/or lymphatic filariasis (LF) has been suspended in areas co-endemic for Loa loa due to severe post-treatment adverse events (SAEs) associated with high-burden of infection (>30,000 mf/ml). One simple approach for preventing SAEs is to identify and exclude individuals at risk from MDA. Here, we describe a repurposed hand-held automated cell counter (Scepter 2.0; HHAC) as a rapid, point-of-care method for quantifying microfilariae (mf) in the blood of infected individuals.The quantification of microfilarial levels in blood of naturally infected humans, experimentally infected baboons, or mf-spiked human blood was tested using a microfluidic-based automated counter and compared to traditional calibrated thick-smears. We demonstrate that mf can be quantified in 20 µl of whole blood following lysis with 10% saponin within a minute of obtaining blood. There was a highly significant concordance between the counts obtained by the HHAC and those by microscopy for mf densities of >5,000 (p<0.0001, r(c) = 0.97) or >30,000 per ml (p<0.0001, r(c) = 0.90). Preliminary proof of concept field studies in Cameroon with 20 µl of blood from L. loa infected humans (n = 22) and baboons (n = 4) also demonstrated a significantly high concordance (p<0.0001, r(c) = 0.89) with calibrated thick blood smears counts.A repurposed HHAC is a portable, sensitive, rapid, point-of-care and quantitative tool to identify individuals with high levels of L. loa mf that put them at risk for SAEs following MDA. In addition, it provides ease of data storage and accessibility.
url http://europepmc.org/articles/PMC4169247?pdf=render
work_keys_str_mv AT sasisekharbennuru repurposedautomatedhandheldcounterasapointofcaretooltoidentifyindividualsatriskofseriouspostivermectinencephalopathy
AT sebastiendspion repurposedautomatedhandheldcounterasapointofcaretooltoidentifyindividualsatriskofseriouspostivermectinencephalopathy
AT josephkamgno repurposedautomatedhandheldcounterasapointofcaretooltoidentifyindividualsatriskofseriouspostivermectinencephalopathy
AT samuelwanji repurposedautomatedhandheldcounterasapointofcaretooltoidentifyindividualsatriskofseriouspostivermectinencephalopathy
AT thomasbnutman repurposedautomatedhandheldcounterasapointofcaretooltoidentifyindividualsatriskofseriouspostivermectinencephalopathy
_version_ 1724810388205207552